Pregabalin placebo

DRUG3 trials

Sponsors

Vertex Pharmaceuticals Inc., Astellas Pharma Global Development, Inc., Daewon Pharmaceutical Co., Ltd.

Conditions

Pain Associated With Diabetic Peripheral NeuropathyPain of MononeuropathyPainful Diabetic Peripheral Neuropathy (PDPN)

Phase 2

Study to Assess Analgesic Efficacy and Safety of ASP3662 in Subjects With Painful Diabetic Peripheral Neuropathy

TerminatedNCT02372578

Astellas Pharma Global Development, Inc.Painful Diabetic Peripheral Neuropathy (PDPN)

Start: 2015-05-27End: 2016-05-20Updated: 2019-03-26

A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of Oral VX-993 in Subjects With Painful Diabetic Peripheral Neuropathy

RecruitingCTIS2024-514689-38-01

Vertex Pharmaceuticals Inc.Pain Associated With Diabetic Peripheral Neuropathy

Start: 2025-05-12Target: 60Updated: 2025-11-20

Phase 3

Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain

CompletedNCT03221907

Daewon Pharmaceutical Co., Ltd.Pain of Mononeuropathy

Start: 2016-04-11End: 2019-01-08Updated: 2019-03-19

Related Papers

1807-P: Cardiometabolic Effects of Clofutriben (CLO) in Adults with Type 2 Diabetes (T2D): A Six-Week, Phase 2, Placebo-Controlled, Randomized Clinical Trial

Diabetes2026-06-05

Efficacy and Safety of the Controlled-release Pregabalin Tablet (GLA5PR GLARS-NF1) and Immediate-release Pregabalin Capsule for Peripheral Neuropathic Pain: A Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Phase III Clinical Trial.

2020-11-301 citations